Markets:

Overview

News

Currencies

International

Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

9.025 +0.025 (+0.28%)

Streaming Delayed Price Updated: 12:45 PM EDT, Aug 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Maravai Lifesciences Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

July 23, 2021

Maravai Lifesciences sees its Relative Strength Rating enter the 80-plus level.

Via Investor's Business Daily

Editas Medicine Stock Shows Improved Relative Strength Rating ↗

July 22, 2021

A Relative Strength Rating upgrade for Editas Medicine shows improving technical performance. Will it continue?

Via Investor's Business Daily

Codex DNA Shares Move Higher On Licensing, Supply Deal With TriLink For mRNA Capping Tech ↗

July 21, 2021

Codex DNA Inc (NASDAQ: DNAY) has announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences Holdings Inc...

Via Benzinga

BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold ↗

July 01, 2021

In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday.

Via Investor's Business Daily

Translate Bio Stock Sees Relative Strength Rating Jump To 88 ↗

June 30, 2021

A Relative Strength Rating upgrade for Translate Bio shows improving technical performance.

Via Investor's Business Daily

Translate Bio Stock Flashes Improved Technical Strength Rating; Triple-Digit Sales Growth ↗

June 28, 2021

Translate Bio shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Crispr Therapeutics Stock Sees Improved Relative Strength Rating ↗

June 25, 2021

Crispr Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 68 to 74.

Via Investor's Business Daily

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Novan Stock Joins Elite Club Of Stocks With RS Ratings Over 90 ↗

June 14, 2021

Novan shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Twist Bioscience Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

June 11, 2021

TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.

Via Investor's Business Daily

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

BioNTech SE Stock Earns Membership In 95-Plus Composite Rating Club ↗

June 10, 2021

The IBD SmartSelect Composite Rating for BioNTech SE stock rose from 94 to 97 Thursday. The Covid-19 vaccine stock also has 98 Relative Strength Rating.

Via Investor's Business Daily

Supernus Pharmaceuticals Stock Getting Closer To Key Technical Measure ↗

June 10, 2021

A Relative Strength Rating upgrade for Supernus Pharmaceuticals shows improving technical performance. Will it continue?

Via Investor's Business Daily

The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex ↗

June 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc...

Via Benzinga

BridgeBio Stock Flashes Healthy 83 RS Rating ↗

June 02, 2021

Look for stocks with a Relative Strength Rating of 80 or higher. BridgeBio stock just hit that mark, with a jump from 79 to 83 Wednesday.

Via Investor's Business Daily

Twist Bioscience Stock Scores Relative Strength Rating Upgrade ↗

May 28, 2021

When adding stocks to your watch list, look for stocks with an 80 or higher RS Rating. Twist Bioscience just met that criteria with a new score of 84.

Via Investor's Business Daily

Cel-Sci Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

May 27, 2021

Cel-Sci stock saw an improvement to its Relative Strength Rating on Thursday, rising from 79 to 87, making the stock a potential watchlist candidate.

Via Investor's Business Daily

Kalvista Pharmaceuticals Stock Shows Rising Relative Strength ↗

May 19, 2021

A Relative Strength Rating upgrade for Kalvista Pharmaceuticals shows improving technical performance.

Via Investor's Business Daily

The Daily Biotech Pulse: Iovance To Delay Regulatory Filing For Cancer Therapy, Departures At Passage Bio, Positive Readout For Silence Therapeutics ↗

May 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) Alexion Pharmaceuticals, Inc...

Via Benzinga

Horizon Therapeutics Stock Flashes Improved Technical Strength; Nears Buy Point ↗

May 18, 2021

Horizon Therapeutics stock had its Relative Strength Rating upgraded to 75 -- a welcome improvement, but still shy of the 80 or better score you look for.

Via Investor's Business Daily

Biotech Zai Lab Stock Sees Relative Strength Rating Jump To 83 ↗

May 14, 2021

A Relative Strength Rating upgrade for ZaiLabLimited shows improving technical performance.

Via Investor's Business Daily

Stock Market Rally Struggles With Inflation Spike; Tesla Sales Fall, Elon Musk Turns On Bitcoin As Coinbase Reports ↗

May 14, 2021

The market rally tested key levels as inflation fears mounted. Tesla's China sales dived as CEO Elon Musk dissed Bitcoin.

Via Investor's Business Daily

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2021 Earnings Call Transcript ↗

May 11, 2021

MRVI earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

IPO Stock Maravai Lifesciences Crushes First-Quarter Forecasts ↗

May 10, 2021

Late Monday, Maravai reported adjusted income of 26 cents per share on $148.21 million in sales. But the fresh IPO stock was unmoved in after-hours trading.

Via Investor's Business Daily

Topics Initial Public Offering

Coronavirus Vaccine Plays Moderna, Maravai, West Pharmaceutical Among 5 Stocks Near Buy Points ↗

April 17, 2021

Coronavirus vaccine maker Moderna and vaccine suppliers Maravai and West Pharmaceutical are among five stocks near buy points.

Via Investor's Business Daily

Topics Supply Chain

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.